Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
SLRX similar filings
- 18 Sep 19 Index to Financial Statements
- 16 Sep 19 Departure of Directors or Certain Officers
- 12 Aug 19 Regulation FD Disclosure
- 24 Jul 19 Entry into a Material Definitive Agreement
- 22 Jul 19 Salarius Pharmaceuticals Announces Closing of Strategic Merger
- 15 Jul 19 Submission of Matters to a Vote of Security Holders
- 1 Jul 19 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 16.1
July 24, 2019
To the Office of the Chief Accountant of the
U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, District of Columbia 20549
Dear Ladies and Gentlemen:
We have read item 4.01 on Form 8-K of Salarius Pharmaceuticals, Inc. dated July 22, 2019, and agree with the statements concerning our Firm contained therein.
/s/ WEAVER AND TIDWELL, L.L.P.
WEAVER AND TIDWELL, L.L.P.